1. FDA's policy statement for the development of new stereoisomeric drugs, 57 Fed. Reg., 22249;Food & Drug Administration,1992
2. Stereochemistry in drug action;McConathy;J Clin Psychiatry,2003
3. Chiral separations;Rekoske;AIChE J,2001
4. Chiral HPLC for efficient resolution of enantiomers;Okamoto;Chem Soc Rev,2008
5. Trends in the development of chiral drugs;Caner;DDT,2004